Replimune plans layoffs as FDA rejects cancer drug Source link Like this:Like Loading... Related Post navigation Pump prices likely to stay high after posting biggest monthly increase in nearly 60 years Trending stocks this week as ceasefire hopes lift sentiment amid U.S.-Israel-Iran Tensions